Cellectar Biosciences, Inc.
CLRB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001279704
No open-market purchases or sales by Cellectar Biosciences, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $9.69M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Cellectar Biosciences, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 29
- +10 vs. Q1 2026
- Shares held
- 3.48M
- +3.17M (+1,019.9%) vs. Q1 2026
- Total value
- $9.69M
- +$8.88M (+1,092.2%) vs. Q1 2026
- New holders
- 14
- 6 more added
- Sold out
- 4
- 2 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLRB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 29 | $9.69M |
| Q1 2026 | 19 | $812.9K |
| Q4 2025 | 20 | $1.04M |
| Q3 2025 | 21 | $1.65M |
| Q2 2025 | 19 | $734.0K |
| Q1 2025 | 32 | $1.63M |
| Q4 2024 | 30 | $1.52M |
| Q3 2024 | 35 | $30.0M |
| Q2 2024 | 37 | $33.0M |
| Q1 2024 | 45 | $36.5M |
| Q4 2023 | 26 | $27.6M |
| Q3 2023 | 20 | $3.85M |
| Q2 2023 | 21 | $3.08M |
| Q1 2023 | 21 | $2.43M |
| Q4 2022 | 26 | $3.22M |
| Q3 2022 | 22 | $2.14M |
| Q2 2022 | 33 | $3.65M |
| Q1 2022 | 32 | $4.69M |
| Q4 2021 | 42 | $4.41M |
| Q3 2021 | 40 | $6.77M |
| Q2 2021 | 46 | $14.9M |
| Q1 2021 | 45 | $24.2M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Cellectar Biosciences, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Caligan Partners LP | 469,998 | $1.31M | 0.06% | +469,998 | New |
| Nantahala Capital Management, LLC | 439,996 | $1.22M | 0.04% | +439,996 | New |
| StemPoint Capital LP | 354,938 | $986.7K | 0.17% | +354,938 | New |
| Vanguard Capital Management LLC | 327,367 | $910.1K | 0.00% | +245,483+299.8% | Added |
| Silverarc Capital Management, LLC | 321,728 | $894.4K | 0.10% | +321,728 | New |
| Bleichroeder LP | 288,679 | $802.5K | 0.14% | +188,679+188.7% | Added |
| Jupiter Topco LLC | 274,156 | $759.4K | 0.00% | +274,156 | New |
| Balyasny Asset Management LLC | 220,000 | $611.6K | 0.00% | +220,000 | New |
| Empery Asset Management, LP | 189,605 | $527.1K | 0.61% | +189,605 | New |
| Diadema Partners LP | 138,341 | $384.6K | 0.14% | +138,341 | New |
| Stonepine Capital Management, LLC | 104,550 | $290.6K | 0.22% | +104,550 | New |
| Persistent Asset Partners Ltd | 92,983 | $258.5K | 0.08% | +92,983 | New |
| Boothbay Fund Management, LLC | 85,069 | $236.5K | 0.00% | +85,069 | New |
| Geode Capital Management, LLC | 53,351 | $148.3K | 0.00% | +573+1.1% | Added |
| Vanguard Fiduciary Trust Co | 46,220 | $128.5K | 0.00% | +29,647+178.9% | Added |
| Sequoia Financial Advisors, LLC | 21,850 | $60.7K | 0.00% | +3,000+15.9% | Added |
| Riverview Capital Advisers, LLC | 10,384 | $50.1K | 0.01% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 16,577 | $46.0K | 0.00% | +16,577 | New |
| Northern Trust Corp | 14,839 | $41.3K | 0.00% | +14,839 | New |
| BlackRock, Inc. | 4,735 | $13.2K | 0.00% | −10−0.2% | Reduced |
| UBS Group AG | 3,093 | $8.60K | 0.00% | −6,554−67.9% | Reduced |
| Barclays PLC | 561 | $1.56K | 0.00% | +561 | New |
| Morgan Stanley | 510 | $1.42K | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 63 | $178 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 11 | $31 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 7 | $18 | 0.00% | +6+600.0% | Added |
| US Bancorp | 3 | $8 | 0.00% | 00.0% | Unchanged |
| Jones Financial Companies LLLP | 3 | $8 | 0.00% | 00.0% | Unchanged |
| Danske Bank A/S | 2 | $6 | 0.00% | 00.0% | Unchanged |
| Warberg Asset Management LLC | 0 | $0 | 0.00% | −13,900−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −793−100.0% | Sold out |
| Vanguard Global Advisers, LLC | 0 | $0 | 0.00% | −563−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |